Skip to main content

Table 2 Psychiatric medication

From: Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study

 

SCZ without T2D

SCZ with T2D

Monotherapy

 FGA

246 (17.7%)

127 (9.14%)

 SGA

126 (9.06%)

89 (6.40%)

Combination Therapy

 2-Drug Combination (Antipsychotic + 1 more psychiatric medication)

361 (25.97%)

209 (15.04%)

 ≥3-Drug Combination (Antipsychotic + 2 or more psychiatric medications)

121 (8.71%)

111 (7.99%)

  1. FGA first generation antipsychotics, SGA second generation antipsychotics